This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: cancer therapies
María José Alonso’s Lab participates in the ONCOLIBERIX Consortium for the development of oncological drugs of marine origin
December 2, 2022This consortium, led by PharmaMar, brings together four leading research groups in nanotechnology and oncology.
Read More